CCR5 and cancer: Maraviroc, an antagonist of CC-chemokine receptor 5 (CCR5), is a potent antiretroviral drug used to treat human immunodeficiency virus (HIV) infection [16,17] and prevents development of cancer cells in animal studies [18].